The GW Cancer Center and the GW School of Medicine and Health Sciences will have a large presence at the upcoming American Academy of Dermatology Association Annual Meeting in Washington, D.C.
A team from the GW Cancer Center has been approved for a funding award from the Patient-Centered Outcomes Research Institute to disseminate patient-driven standards for quality cancer survivorship care.
A new reversible, drug-free antiplatelet therapy could reduce the risk of blood clots and potentially prevent cancer metastasis, according to a study published in Science Translational Medicine.
Anne-Laure Papa, PhD, is a member of our Cancer Engineering and Technology Research Program. Her work in the School of Engineering and Applied Science focuses on disease processes, particularly in cancer and vascular diseases. Learn about her collaborative research at the intersection of chemistry, biology and medicine.
Read more.
